Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
Accupro 10 mg film-coated tablets.
Pharmaceutical Form |
---|
Film-coated tablet. Reddish-brown, triangular, film-coated tablets, scored on both sides and “10” debossed on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
10 mg quinapril (as 10.832 mg quinapril hydrochloride).
Excipient(s) with known effect: Lactose, 72 mg per tablet.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Quinapril |
Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion. |
List of Excipients |
---|
Magnesium carbonate Colourings: Opadry Y-5-9020 (containing hydroxypropyl methylcellulose, hydroxypropyl cellulose, Macrogol 400, red iron oxide (E172) and titanium dioxide (E171)) |
Tampertainers with desiccant containing 56 or 100 tablets.
Polyamide/aluminium/PVC blister strip containing 7, 28, 56 or 100 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom
PL 00057/0515
Date of first authorisation: 01 August 2003
Date of latest renewal: 14 February 2006
Drug | Countries | |
---|---|---|
ACCUPRO | Austria, Germany, Finland, Ireland, Lithuania, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.